Utilizing novel fluorothymidine PET imaging in a phase I study of veliparib on an intermittent and continuous schedule given in combination with carboplatin in metastatic breast cancer Preprint

Wesolowski, Robert, Stover, Daniel G, Lustberg, Maryam B et al. Utilizing novel fluorothymidine PET imaging in a phase I study of veliparib on an intermittent and continuous schedule given in combination with carboplatin in metastatic breast cancer . 10.1101/2020.01.20.20018218

cited authors

  • Wesolowski, Robert; Stover, Daniel G; Lustberg, Maryam B; Shoben, Abigail; Zhao, Meng; Mrozek, Ewa; Layman, Rachel M; Macrae, Erin; Duan, Wenrui; Zhang, Jun; Hall, Nathan; Wright, Chadwick L; Schregel, Katharina; Gillespie, Susan; Berger, Michael; Camp, Andrea; Chalmers, Jeffrey J; Balasubramanian, Priya; Miller, Brandon L; Amaya, Peter; Andreopoulou, Eleni; Sparano, Joseph; Shapiro, Charles L; Villalona-Calero, Miguel Angel; Geyer, Susan; Chen, Alice; Grever, Michael R; Knopp, Michael V; Ramaswamy, Bhuvaneswari

authors

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • Biomedical Imaging
  • Breast Cancer
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Hematology
  • Women's Health

Digital Object Identifier (DOI)